Definium Therapeutics, Inc. DFTX
35.39 USD +2.12 (+6.37%)
At closeNov 10, 2026, 4:00 AM EST
35.50 +0.11 +0.31%
Pre-market · Nov 10, 4:00 AM ET
33.35 Day range 35.43
10.47 52-week range 49.70
- YTD
- +164.30%
- 1 year
- +202.48%
News
seekingalpha.com Definium Therapeutics, Inc. (DFTX) Q3 2026 Earnings Call Transcript Definium Therapeutics, Inc. (DFTX) Q3 2026 Earnings Call Transcript
benzinga.com Definium Therapeutics Q3 2026 Earnings Call Transcript Definium Therapeutics (NASDAQ:DFTX) reported third-quarter financial results on Monday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is…
businesswire.com Definium Therapeutics Presents Topline Phase 3 Data for DT120 ODT in Generalized Anxiety Disorder and Major Depressive Disorder at 2026 NEI Fall Congress NEW YORK--(BUSINESS WIRE)-- #ClinicalTrials--Definium Therapeutics, Inc. (Nasdaq: DFTX) (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of…
businesswire.com Definium Therapeutics to Participate at Upcoming Investor Conferences NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (Nasdaq: DFTX) ("Definium" or the "Company"), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics…